Ion-Pair Reversed-Phase Liquid Chromatography Method for Analysis of mRNA Poly(A) Tail Heterogeneity
Applications | 2023 | WatersInstrumentation
The poly(A) tail at the 3′ end of messenger RNA plays a pivotal role in transcript stability and translational efficiency. In emerging mRNA-based therapeutics and vaccines, precise characterization of poly(A) tail length distribution is critical for ensuring product consistency and performance.
This study aimed to establish a robust ion-pair reversed-phase liquid chromatography (IP RP LC) with ultraviolet detection method to resolve and quantify heterogeneity in mRNA poly(A) tails. Key objectives included liberation of the poly(A) region via enzymatic digestion, high-resolution separation of length variants up to ~150 nucleotides, and length assignment through calibrated retention times.
Messenger RNA samples were digested with RNase T1 to cleave after guanine residues, releasing the intact poly(A) tail. A subsequent phosphatase treatment removed terminal phosphates. Clean-up was performed using Oasis HLB µElution plates. Separation was achieved on a Waters ACQUITY Premier UPLC system equipped with SM-FTN and QSM units and inline PDA detection at 260 nm. The column was an ACQUITY Premier Oligonucleotide BEH C18 300 Å (2.1 × 150 mm, 1.7 µm) maintained at 60 °C. A binary ion-pairing mobile phase containing 100 mM octylammonium acetate in acetonitrile/HFIP gradients was employed at 0.3 mL/min over 40 minutes.
Optimized conditions provided n/n-1 resolution for oligoribonucleotides up to approximately 150 nt. A synthetic 100 nt oligo(A) standard and its shorter impurities were used to construct a linear calibration of retention time versus chain length. Application to RNase T1 digests of EPO and Fluc Beta mRNA revealed dominant poly(A) species at 124 nt and 128 nt, respectively. Results were corroborated by complementary LC-MS and size-exclusion UV analyses.
Advancements may include integration with mass spectrometry for detailed sequence analysis, automated sample preparation workflows, novel stationary phase chemistries for improved resolution beyond 150 nt, and expanded use of complementary nucleases to interrogate adjacent regions.
We report a robust IP RP LC-UV platform capable of resolving and quantifying mRNA poly(A) tail heterogeneity up to ~150 nt. This method supports critical quality attributes in mRNA therapeutic development, offering reliable, calibrated, and reproducible length measurements using standard chromatographic equipment.
HPLC
IndustriesPharma & Biopharma
ManufacturerWaters
Summary
Significance of the Topic
The poly(A) tail at the 3′ end of messenger RNA plays a pivotal role in transcript stability and translational efficiency. In emerging mRNA-based therapeutics and vaccines, precise characterization of poly(A) tail length distribution is critical for ensuring product consistency and performance.
Goals and Overview
This study aimed to establish a robust ion-pair reversed-phase liquid chromatography (IP RP LC) with ultraviolet detection method to resolve and quantify heterogeneity in mRNA poly(A) tails. Key objectives included liberation of the poly(A) region via enzymatic digestion, high-resolution separation of length variants up to ~150 nucleotides, and length assignment through calibrated retention times.
Methodology and Instrumentation
Messenger RNA samples were digested with RNase T1 to cleave after guanine residues, releasing the intact poly(A) tail. A subsequent phosphatase treatment removed terminal phosphates. Clean-up was performed using Oasis HLB µElution plates. Separation was achieved on a Waters ACQUITY Premier UPLC system equipped with SM-FTN and QSM units and inline PDA detection at 260 nm. The column was an ACQUITY Premier Oligonucleotide BEH C18 300 Å (2.1 × 150 mm, 1.7 µm) maintained at 60 °C. A binary ion-pairing mobile phase containing 100 mM octylammonium acetate in acetonitrile/HFIP gradients was employed at 0.3 mL/min over 40 minutes.
Main Results and Discussion
Optimized conditions provided n/n-1 resolution for oligoribonucleotides up to approximately 150 nt. A synthetic 100 nt oligo(A) standard and its shorter impurities were used to construct a linear calibration of retention time versus chain length. Application to RNase T1 digests of EPO and Fluc Beta mRNA revealed dominant poly(A) species at 124 nt and 128 nt, respectively. Results were corroborated by complementary LC-MS and size-exclusion UV analyses.
Benefits and Practical Applications
- High-resolution profiling of poly(A) length distributions for quality control.
- UV-based detection enables straightforward implementation in regulated labs.
- Calibration with synthetic standards allows accurate length assignment.
Future Trends and Opportunities
Advancements may include integration with mass spectrometry for detailed sequence analysis, automated sample preparation workflows, novel stationary phase chemistries for improved resolution beyond 150 nt, and expanded use of complementary nucleases to interrogate adjacent regions.
Conclusion
We report a robust IP RP LC-UV platform capable of resolving and quantifying mRNA poly(A) tail heterogeneity up to ~150 nt. This method supports critical quality attributes in mRNA therapeutic development, offering reliable, calibrated, and reproducible length measurements using standard chromatographic equipment.
Reference
- Donegan M, Nguyen JM, Gilar M. J Chromatogr A. 2022;1666:462860. doi:10.1016/j.chroma.2022.462860.
- Gilar M et al. J Chromatogr A. 2002;958:167-182.
- Roussis SG et al. J Chromatogr A. 2019;1594:105-111. doi:10.1016/j.chroma.2019.02.026.
- Guimaraes GJ et al. J Pharm Biomed Anal. 2022;208:114439. doi:10.1016/j.jpba.2021.114439.
- Goyon A et al. J Pharm Biomed Anal. 2020;182:113105. doi:10.1016/j.jpba.2020.113105.
- Jiang T et al. Anal Chem. 2019;91:8500-8506. doi:10.1021/acs.analchem.9b01664.
- Ivleva VB et al. Rapid Commun Mass Spectrom. 2010;24:2631-2640. doi:10.1002/rcm.4683.
- França LT et al. Q Rev Biophys. 2002;35:169-200. doi:10.1017/s0033583502003797.
- Carrilho E et al. Anal Chem. 1996;68:3305-3313.
- Gilar M et al. J Chromatogr B Biomed Sci Appl. 1998;714:13-20.
- Thayer JR. Thermo Sci Appl note. 2014;21996.
- Huber CG et al. LC-GC. 1996;14:114-127.
- Gilar M, Neue UD. J Chromatogr A. 2007;1169:139-150. doi:10.1016/j.chroma.2007.09.005.
- McCarthy SM et al. Anal Biochem. 2009;390:181-188. doi:10.1016/j.ab.2009.03.042.
- Nguyen JM et al. Bioanalysis. 2021. doi:10.4155/bio-2021-0115.
- Gilar M et al. J Chromatogr A. 2021;1650:462247. doi:10.1016/j.chroma.2021.462247.
- DeLano M et al. Anal Chem. 2021;93:5773-5781. doi:10.1021/acs.analchem.0c05203.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Size-Exclusion Chromatography Method for Poly(A) Tail Analysis of mRNA
2023|Waters|Applications
Application Note Size-Exclusion Chromatography Method for Poly(A) Tail Analysis of mRNA Martin Gilar Waters Corporation Abstract The first in-class therapeutic messenger RNA (mRNA) vaccines were successfully developed against SARS-CoV2 virus. Therapeutic mRNA molecules can also be used for protein replacement…
Key words
tail, tailpoly, polymrna, mrnaexclusion, exclusionsize, sizechromatography, chromatographymethod, methodanalysis, analysissec, secqsm, qsmftn, ftnpremier, premiergilar, gilaruplc, uplcacquity
Characterization of in vitro-transcribed (IVT) mRNA poly(A) tail by LC-HRAM-MS and BioPharma Finder 5.0 software
2022|Thermo Fisher Scientific|Applications
Application note | 001183 Biopharma Characterization of in vitro-transcribed (IVT) mRNA poly(A) tail by LC-HRAM-MS and BioPharma Finder 5.0 software Authors Application benefits Robert L. Ross1, Jenny England2, Rhonda • Confident identification and sequence confirmation of polyadenylated tails in synthetic…
Key words
poly, polytail, tailfinder, finderbiopharma, biopharmapolyadenylated, polyadenylatedmass, massdeconvolution, deconvolutionrelative, relativeabundance, abundancemrna, mrnathermo, thermomonoisotopic, monoisotopicintact, intactdeconvoluted, deconvolutedonec
Characterizing LNP mRNA
2024|Waters|Guides
CONSUMABLES GUIDE BOOK Characterizing LNP mRNA LC tools for purity, identity, integrity and concentration determining measurements A Changing Industry mRNA based medicine helped address the COVID-19 pandemic. The viability of using an mRNA construct as a human drug substance has…
Key words
lipid, lipidmrna, mrnarplc, rplcvanguard, vanguardlnp, lnpanion, anionbook, bookaex, aexcolumn, columndiameter, diameterfit, fitconsumables, consumablesguide, guidecsh, csholigo
Characterization of Intact mRNA Using Ion Pair-Reversed Phase-Time of Flight-MS, Size Exclusion Chromatography-Multi Angle Light Scattering, and Charge Detection Mass Spectrometry Patrick Brophy1; Henry Shion1; Catalin E Doneanu1; Hua Yang1; Benjamin Draper2; Daniel Botamanenko2; Susan Abbatiello1; Andy Jarrell1; Stephan Koza1;…
Key words
cdms, cdmsmrna, mrnamda, mdamass, massintact, intactmals, malsfluc, fluctechniques, techniquessec, sectof, tofvaccines, vaccinesdimer, dimercharge, chargeintensity, intensityminutes